Dr. Gagneten completed her graduate studies at the Uniformed Services University for the Health Sciences (USUHS) in Maryland and conducted research in virology and genetic recombination before joining the Office of Vaccines Research and Review (OVRR) at CBER, FDA. Currently she is the Associate Division Director for Policy in the Division of Viral Products. She has extensive experience in the regulatory aspects of vaccine development and manufacture.